글로벌 합성 생물학 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

합성생물학은 다이옥신, 살충제 , 심지어 방사성 물질과 같은 내화성 물질을 소화하는 합성 미생물을 포함한 위험한 정화 프로젝트에 대한 호소력을 얻은 환경적으로 양성인 기술입니다 . 합성생물학은 의료 산업의 가격 상승을 안정화하는 데 도움이 되며, 이는 이 시장에 대한 수요를 증가시킵니다. DNA 합성 기술과 클러스터링된 규칙적으로 간격을 둔 짧은 팰린드롬 반복 접근법은 암과 당뇨병과 같은 만성 질환의 발생률을 낮추는 데 도움이 되었습니다. 생물의학, 제약, 농업, 바이오연료 및 화학 산업은 모두 이 기술의 주요 사용자입니다. 농부들은 합성생물학으로 더 적은 면적에서 더 많은 작물을 재배할 수 있으며, 이전의 유전자 기술보다 더 정확하고 완벽합니다.

Data Bridge Market Research는 2021년에 95억 달러였던 합성생물학 시장이 2029년까지 488억 1천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지의 예측 기간 동안 22.70%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

합성생물학은 공학과 과학을 결합하여 실용적인 응용 분야가 있는 독특한 생물학적 시스템을 만듭니다. 합성생물학은 세포, 효소, 유전 회로와 같은 새로운 생물학적 단위를 만들고 기존 생물학적 시스템을 수정하는 과정입니다. 합성생물학의 주요 목표는 고급 바이오연료, 재생 가능한 화학 물질, 바이오 제품과 같이 자연에 존재하지 않는 새로운 생물학적 구성 요소를 만드는 것입니다. 합성생물학은 표준화된 게놈 단위를 발견하여 작은 게놈 부분을 빠르게 합성하고 조립하여 통합된 대형 시스템으로 만들어 생물학적 시스템 개발에 대한 특정 생물학적 어려움을 해결하는 데 활용할 수 있습니다.

합성생물학 시장 동향

운전자

• 합성의약품과 백신의 증가

단백질 요법과 개인 맞춤 의학에 대한 수요가 증가하고 합성 의약품과 백신에 대한 연구가 증가함에 따라 시장이 확대될 것으로 예상됩니다. 합성 생물학 응용 ​​프로그램 증가, 합성 생물학 투자 증가, DNA 시퀀싱 및 합성 비용 감소, R&D 지출 및 활동 증가와 같은 다른 요인은 2022년에서 2029년의 예측 기간 동안 합성 생물학 시장 확대를 가속화할 가능성이 높습니다.

• 연구 개발 자금 증가

R&D spending in the life sciences industry climbed by 22% from 2018 to 2019, according to a Business Wire report published in September 2020. Pharmaceutical companies have received more funds for research and development in order to discover new therapies. The government has made steps to fund various pharmaceutical and biotech enterprises in order to advance pharmaceutically and boost international competitiveness. As a result, R&D spending and funding have steadily rised throughout the years. Pharmaceutical and biotechnology businesses devote significant resources to research in order to create game-changing compounds that will meet the expanding demands of the healthcare industry and tackle emerging ailments. Pharmaceutical research and development accounts for more than 80% of all R&D spending in the life sciences industry.

• Improving diagnosis and better treatment

Synthetic biology is used in the healthcare industry because it can help improve diagnostics and offer better treatment options for a variety of diseases by targeting only the disease site and creating no side effects. In addition, the use of genetically designed viruses to fix damaged genes in patients with inherited disorders such as epidermolysis bullosa or severe combined immune deficiency (SCID) has increased significantly. Aside from that, technologies for executing synthetic biology are becoming more accessible, and internet usage has facilitated free interchange of ideas and information, encouraging market expansion. Furthermore, the market is being influenced positively by significant expansion in the healthcare sector and an increase in the number of synthetic biology research units around the world.

Opportunities

• Demand for fuel alternatives

Biofuels are becoming increasingly important as fuel use rises and concerns about energy security develop. Annually, nearly 150 billion tonnes of biomass are produced worldwide. Biofuels are currently made from edible commodities such as maize, sugarcane, and vegetable oil. As a result, synthetic biology techniques are becoming more widely used in renewable energy development.

Restraints/Challenges

• Ethical and biosafety concerns

The purposeful or unintentional release of synthetic organisms into the environment during research and other purposes is the primary biosafety risk in synthetic biology. When synthetic microorganisms are released into the environment, they might mutate or interact with existing organisms, potentially causing crossbreeding and bio errors. These repercussions may pose a hazard to natural creatures' ecosystems. Additionally, the emergence of antibiotic-resistant superbugs is a huge biosecurity risk. In recent years, the European Union (EU) has supported a number of studies into the environmental impact of genetically altered bacteria released for plant growth or bioremediation. These factors may limit the market's growth in the following years.

This synthetic biology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the synthetic biology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Synthetic Biology Market

Pharmaceutical and biopharmaceutical businesses and synthetic biology market players have stepped up to help with global research efforts by providing synthetic biology for producing test kits, therapies, and vaccinations to combat coronavirus infection. A report from the European Parliament highlights synthetic biology as one of the developing technologies. It has the ability to combat the COVID-19 pandemic. The US National Institute of Health has also suggested synthetic biology as a technique to accelerate vaccine development. By employing their engineering methodologies founded on a range of data, synthetic biology technologies have the potential to alter the research and manufacture of vaccines, medicines, and diagnostics (genomic sequences, sequence annotations, enzyme properties, metabolic models, lab protocols, algorithms, and scientific knowledge). Vaccine technologies based on DNA and mRNA, for example, can make vaccine development and manufacture easier. These vaccines are made up of synthetic nucleotide strands that cause proteins to develop in the individual's own cells, triggering an immunological response. As a result of the availability of viral sequencing data, vaccination candidates can be developed quickly. This has allowed companies like Moderna and Inovio to proceed quickly into clinical development.

Recent Development

• In January 2021, Frontia GlutenEx was developed by Novozymes. It would assist wheat processors in improving gluten protein recovery while reducing energy use.
• In February 2021, Merck collaborated with BioNTech (Germany) to provide lipids for the Pfizer-BioNTech COVID-19 vaccine (BNT162b2).
• In January 2021, Merck bought AmpTec (Germany). The company expanded its product portfolio by developing and manufacturing mRNA for use in vaccinations, therapies, and diagnostics as a result of this purchase.

Global Synthetic Biology Market Scope

The synthetic biology market is segmented on the basis of tool, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Tool

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

Technology

• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modeling
• Microfluidics
• Nanotechnology

Application

• Medical Application
• Pharmaceuticals
• Drug Discovery and Therapeutics
• Cancer Detection and Diagnostics
• Other Drug Discovery and Therapeutic Applications
• Artificial Tissue and Tissue Regeneration
• Bio-synthesis
• Stem Cell Regulation
• Other Tissue and Tissue Regeneration Applications
• Industrial Applications
• Biofuel and Renewable Energy
• Biomaterials and Green Chemicals
• Industrial Enzymes, by Application
• Textile Industry
• Paper Industry
• Consumer Care Industry
  • Skin Care and Cosmetics
  • Other Consumer Care Products
  • Other Industries
• Food and Agriculture
• Environmental Applications
• Bioremediation
• Biosensing

Synthetic biology Market Regional Analysis/Insights

The synthetic biology market is analysed and market size insights and trends are provided by country, tool, technology and application as referenced above.

The countries covered in the synthetic biology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 North America dominating the synthetic biology market, due to various factors such as the increase in the number of well-established synthetic biology companies and research institutes in the US and Canada.

Asia-Pacific is expected to grow the synthetic biology market in the forecast period of 2022 to 2029 due to the growing number of pharmaceutical and biopharmaceutical companies and increasing healthcare and life science facilities which is expected to improve the synthetic biology market in forecast period.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다. 

경쟁 환경 및 합성 생물학 시장 점유율 분석

합성 생물학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 합성 생물학 시장과 관련된 회사의 초점에만 관련이 있습니다.

합성생물학 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Thermo Fisher Scientific Inc. (미국)
• 머크 KGaA(독일)
• Agilent Technologies, Inc. (미국)
• Novozymes(덴마크)
• 깅코 바이오웍스(미국)
• 아미리스(미국)
• Precigen Inc. (미국)
• GenScript(중국)
• 트위스트 바이오사이언스(미국)
• 합성 유전체학(미국)
• 코덱시스 주식회사 (미국)
• 신테고(미국)
• 크리에이티브 효소(미국)
• Eurofins Scientific(룩셈부르크)
• 사이러스 바이오테크놀로지 주식회사(미국)
• ATUM(미국)
• 테셀라젠(미국)
• 아르제다(미국)
• Integrated DNA Technologies Inc. (미국)
• 뉴잉글랜드 바이오랩스(미국)

SKU-52787